Nanosonics

Rising Hospital Cost Containment And Tech Obsolescence Will Erode Profitability

AnalystLowTarget

Not Invested

Consensus Narrative from 8 Analysts

Published

18 Jul 25

AnalystLowTarget's Fair Value

AU$3.90

6.7% overvalued

04 Sep

AU$4.16

15.6%

6.9%

15.6%

6.9%

You can edit this narrative until Jul 18 10:25 PM. Then, changes will post as Updates.

Author's Valuation

AU$3.9

6.7% overvalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

AU$3.9

6.7% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

9.17%

Medical Equipment revenue growth rate

0.40%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.04%

Calculation

AU$18.34m

Earnings '28

77.61x

PE Ratio '28

AU$1.42b

Market Cap '28

AU$1.42b

Market Cap '28

297.23m

No. shares '28

AU$4.79

Share Price '28

AU$4.79 Share Price '28

Discounted to 2025 @ 7.11% p.a.

AU$3.90

Fair Value '25